Recombinant Saccharomyces cerevisiae DNA ligase 1 (CDC9), partial

What is CDC9 and what are its primary functions?

CDC9 is the structural gene that encodes DNA ligase I in Saccharomyces cerevisiae. This essential enzyme plays critical roles in both nuclear and mitochondrial DNA metabolism. In the nucleus, Cdc9p (the protein product) is primarily responsible for joining Okazaki fragments during lagging-strand DNA synthesis. It also participates in various DNA repair pathways, including nucleotide excision repair and base excision repair. In mitochondria, Cdc9p appears to be the sole DNA ligase responsible for mitochondrial DNA replication and recovery . The protein is dual-targeted to both cellular compartments through differential mRNA processing, resulting in distinct nuclear and mitochondrial isoforms .

How is CDC9 gene expression regulated?

CDC9 expression is regulated in a cell cycle-dependent manner and in response to DNA damage. The steady-state level of DNA ligase mRNA increases approximately fourfold in late G1 phase, after the completion of START but before S phase. This elevated level subsequently decays with an apparent half-life of about 20 minutes, returning to a low basal level for the remainder of the cell cycle . Importantly, the accumulation of CDC9 mRNA in late G1 depends on the completion of START but does not require CDC7 and CDC8 functions . Additionally, exposure to UV light induces an eightfold increase in DNA ligase mRNA levels, demonstrating that CDC9 expression responds to DNA damage as part of the cellular DNA damage response .

What is the role of Cdc9p in mitochondrial DNA maintenance?

Biochemical and genetic analyses have demonstrated that Cdc9p is the only DNA ligase protein present in yeast mitochondria. When mitochondrial Cdc9p function is inactivated, there is a rapid decline in cellular mitochondrial DNA content in both dividing and stationary yeast cultures . This observation indicates that mitochondrial Cdc9p is essential for maintaining the integrity of the mitochondrial genome. In contrast, deletion of the DNL4 gene (which encodes another DNA ligase in yeast) does not appear to affect mitochondrial DNA dynamics, confirming the specificity of Cdc9p in mitochondrial function .

How does mutation of Cdc9p's high-fidelity magnesium binding site affect mutagenesis?

Mutation of the high-fidelity magnesium binding site in Cdc9p (referred to as Cdc9-EEAA variant) significantly increases the rate of single-base insertions across the nuclear genome . This mutagenic effect is synergistically amplified when DNA mismatch repair (MMR) is also compromised. The insertions occur in highly specific sequence contexts, with a strong preference for adding either dGTP or dTTP into 3-5 base pair mononucleotide sequences that have stringent flanking nucleotide requirements .

These findings suggest a model where high-fidelity DNA ligation by Cdc9p prevents the incorporation of extra bases into the nascent lagging DNA strand during Okazaki fragment maturation. When ligation fidelity is compromised by mutations in the magnesium binding site, extra nucleotides may be incorporated, leading to insertional mutagenesis that can be partially corrected by the MMR system .

What experimental approaches can be used to study Cdc9p localization and function?

Several methodological approaches have been documented for studying Cdc9p:

• Mitochondrial targeting constructs: Researchers have developed constructs containing the CDC9 mitochondrial targeting sequence fused to reporter genes or functional domains. For example, the CDC9 mitochondrial targeting sequence has been PCR-amplified and cloned into expression vectors (e.g., pYES2) to create fusion proteins that can be tracked to mitochondria .

• Biochemical fractionation: Percoll-purified mitochondrial protein extracts can be prepared from various yeast strains (including those harboring mutations in CDC9) to study mitochondrial DNA ligase function in isolation .

• Temperature-sensitive alleles: Since CDC9 is essential for yeast viability, temperature-sensitive alleles (e.g., cdc9-1 ts) are commonly used to conditionally inactivate Cdc9p function and study its effects on DNA metabolism .

• Northern blot analysis: This technique can be used to monitor CDC9 gene expression under different conditions or in response to various treatments, such as UV irradiation .

How do CDC9 mutations affect Okazaki Fragment Maturation (OFM)?

Finalization of eukaryotic nuclear DNA replication relies on Cdc9p to seal DNA nicks generated during Okazaki Fragment Maturation (OFM). The process involves several coordinated steps:

• Okazaki fragments are initiated by DNA polymerase α-primase and extended by DNA polymerase δ in cooperation with PCNA .

• When polymerase δ reaches the 5'-end of a downstream DNA fragment, it performs nick translation/strand displacement synthesis, creating a 5'-flap that must be removed .

• Short flaps are cleaved by the flap endonuclease Fen1 (RAD27), generating a DNA nick with ligatable 5'-phosphate and 3'-hydroxyl ends .

• Cdc9p then seals these nicks to complete lagging strand synthesis .

Mutations in Cdc9p's high-fidelity magnesium binding site compromise its ability to accurately ligate these nicks, potentially allowing incorporation of extra nucleotides and leading to single-base insertions in specific sequence contexts. This reveals that high-fidelity DNA ligation by Cdc9p is critical for preventing mutagenesis across the genome during OFM .

How can recombinant Cdc9p be expressed and purified for in vitro studies?

The expression and purification of recombinant Cdc9p typically involves the following methodological steps:

• Cloning of CDC9 gene: The CDC9 gene can be PCR-amplified from S. cerevisiae genomic DNA using sequence-specific primers. For mitochondrial studies, specific attention should be paid to include the mitochondrial targeting sequence if relevant to the research question .

• Vector construction: The amplified gene is cloned into an appropriate expression vector. For example, the pYES2 vector under the control of the GAL1 promoter has been successfully used for CDC9 expression .

• Expression system: Depending on the research goals, CDC9 can be expressed in various systems:

  • In S. cerevisiae for studying native function and regulation

  • In E. coli for high-yield protein production

  • In mammalian cells for comparative studies across species

• Protein purification: Recombinant Cdc9p is typically purified using affinity chromatography with appropriate tags (His-tag, GST-tag) followed by ion-exchange and/or size exclusion chromatography.

• Activity assessment: DNA ligase activity assays can be performed using oligonucleotide substrates containing a nick to assess the functional integrity of the purified protein .

What assays can be used to measure Cdc9p enzymatic activity?

Several biochemical assays have been developed to assess Cdc9p DNA ligase activity:

Table 1: Common Assays for Measuring Cdc9p Activity

When performing these assays with recombinant Cdc9p, it's important to optimize reaction conditions including buffer composition, pH, temperature, and metal ion concentration (particularly magnesium, which is crucial for high-fidelity activity) .

How do Cdc9p mutations contribute to genome instability?

Mutations in Cdc9p, particularly those affecting the high-fidelity magnesium binding site, have been shown to increase genome instability through several mechanisms:

• Increased single-base insertions: The Cdc9-EEAA variant exhibits a significantly elevated rate of single-base insertions across the nuclear genome, with specific sequence context preferences .

• Synergistic effects with MMR deficiency: When Cdc9p mutations occur in conjunction with defects in the DNA mismatch repair pathway, there is a synergistic increase in mutation rates, suggesting that MMR serves as a backup mechanism to correct errors that arise from compromised ligation fidelity .

• Sequence-specific mutational hotspots: Insertion mutations occur preferentially at 3-5 base pair mononucleotide sequences with specific flanking nucleotide requirements, creating distinct mutational signatures .

What are the key differences between nuclear and mitochondrial functions of Cdc9p?

While Cdc9p functions in both nuclear and mitochondrial compartments, there are important distinctions in its roles and regulation:

Table 2: Comparison of Nuclear vs. Mitochondrial Cdc9p Functions

Research has confirmed that S. cerevisiae relies on a single DNA ligase, Cdc9p, to carry out mitochondrial DNA replication and recovery. When mitochondrial Cdc9p function is inactivated, there is a rapid decline in cellular mitochondrial DNA content in both dividing and stationary yeast cultures, while no apparent defect in mitochondrial DNA dynamics is observed in strains deficient in Dnl4p .

How can contradictory data regarding Cdc9p function be reconciled?

When researchers encounter seemingly contradictory data regarding Cdc9p function, several methodological approaches can help reconcile these discrepancies:

What are the emerging questions about Cdc9p's role in genome stability?

Several important questions remain to be fully addressed regarding Cdc9p's contribution to genome stability:

• Structural determinants of fidelity: While the high-fidelity magnesium binding site has been identified as critical, other structural elements that contribute to Cdc9p's ligation fidelity remain to be fully characterized.

• Interaction with the replisome: How Cdc9p coordinates with other components of the DNA replication machinery, particularly during Okazaki fragment maturation, requires further investigation.

• Post-translational modifications: The roles of potential post-translational modifications in regulating Cdc9p activity, localization, and interactions with other proteins remain poorly understood.

• Sequence context effects: Understanding why certain sequence contexts are particularly susceptible to mutagenic ligation by defective Cdc9p could provide insights into fundamental aspects of DNA ligation mechanisms .

• Evolutionary conservation: Comparative studies of DNA ligase I across species could reveal conserved features essential for high-fidelity function versus species-specific adaptations.

What methodological advances would enhance our understanding of Cdc9p?

Future research on Cdc9p would benefit from several methodological advancements:

• Single-molecule techniques: Applying single-molecule methods could provide real-time insights into Cdc9p dynamics during DNA replication and repair.

• Genome-wide mutational profiling: High-throughput sequencing approaches could further characterize the mutational signatures associated with Cdc9p defects across the entire genome.

• Structural studies: High-resolution structural analyses of Cdc9p in complex with various DNA substrates would enhance our understanding of its catalytic mechanism and fidelity determinants.

• In vivo imaging: Developing improved methods for tracking Cdc9p localization and dynamics in living cells would help clarify its spatiotemporal regulation during DNA metabolism.

• Synthetic genetic approaches: Systematic genetic interaction screens could identify novel functional connections between Cdc9p and other cellular pathways.